UniProt ID | KPRB_HUMAN | |
---|---|---|
UniProt AC | O60256 | |
Protein Name | Phosphoribosyl pyrophosphate synthase-associated protein 2 | |
Gene Name | PRPSAP2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 369 | |
Subcellular Localization | ||
Protein Description | Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis.. | |
Protein Sequence | MFCVTPPELETKMNITKGGLVLFSANSNSSCMELSKKIAERLGVEMGKVQVYQEPNRETRVQIQESVRGKDVFIIQTVSKDVNTTIMELLIMVYACKTSCAKSIIGVIPYFPYSKQCKMRKRGSIVSKLLASMMCKAGLTHLITMDLHQKEIQGFFNIPVDNLRASPFLLQYIQEEIPDYRNAVIVAKSPASAKRAQSFAERLRLGIAVIHGEAQDAESDLVDGRHSPPMVRSVAAIHPSLEIPMLIPKEKPPITVVGDVGGRIAIIVDDIIDDVDSFLAAAETLKERGAYKIFVMATHGLLSSDAPRRIEESAIDEVVVTNTIPHEVQKLQCPKIKTVDISMILSEAIRRIHNGESMSYLFRNIGLDD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MFCVTPPE -------CCCCCCHH | 5.46 | 19413330 | |
5 | Phosphorylation | ---MFCVTPPELETK ---CCCCCCHHHCCC | 34.02 | 23401153 | |
11 | Phosphorylation | VTPPELETKMNITKG CCCHHHCCCCCCCCC | 48.49 | 26552605 | |
27 | Phosphorylation | LVLFSANSNSSCMEL EEEEECCCCCHHHHH | 37.49 | - | |
29 | Ubiquitination | LFSANSNSSCMELSK EEECCCCCHHHHHHH | 25.41 | - | |
48 | Ubiquitination | RLGVEMGKVQVYQEP HHCCCCCCEEEEECC | 28.34 | - | |
48 | Acetylation | RLGVEMGKVQVYQEP HHCCCCCCEEEEECC | 28.34 | 25953088 | |
52 | Phosphorylation | EMGKVQVYQEPNRET CCCCEEEEECCCCCC | 7.06 | 22817900 | |
52 | Nitration | EMGKVQVYQEPNRET CCCCEEEEECCCCCC | 7.06 | - | |
102 | Ubiquitination | ACKTSCAKSIIGVIP HHHHHHHHHHHHEEC | 46.65 | 21906983 | |
115 | Ubiquitination | IPYFPYSKQCKMRKR ECCCCCCCCCCCCCC | 54.60 | - | |
115 | Acetylation | IPYFPYSKQCKMRKR ECCCCCCCCCCCCCC | 54.60 | 25953088 | |
144 | Phosphorylation | AGLTHLITMDLHQKE HCCCEEEECCCCCCH | 15.82 | 18491316 | |
165 | Ubiquitination | IPVDNLRASPFLLQY CCHHHCCCCHHHHHH | 25.40 | 19608861 | |
165 | Acetylation | IPVDNLRASPFLLQY CCHHHCCCCHHHHHH | 25.40 | 19608861 | |
165 | Ubiquitination | IPVDNLRASPFLLQY CCHHHCCCCHHHHHH | 25.40 | 21906983 | |
188 | Ubiquitination | RNAVIVAKSPASAKR CCEEEEECCHHHHHH | 46.18 | 2190698 | |
188 | Acetylation | RNAVIVAKSPASAKR CCEEEEECCHHHHHH | 46.18 | 133515 | |
189 | Phosphorylation | NAVIVAKSPASAKRA CEEEEECCHHHHHHH | 18.89 | 28857561 | |
192 | Phosphorylation | IVAKSPASAKRAQSF EEECCHHHHHHHHHH | 37.39 | 23312004 | |
194 | Acetylation | AKSPASAKRAQSFAE ECCHHHHHHHHHHHH | 45.85 | 133519 | |
198 | Phosphorylation | ASAKRAQSFAERLRL HHHHHHHHHHHHHHH | 25.99 | 26657352 | |
211 | Acetylation | RLGIAVIHGEAQDAE HHCEEEEECCCCCCH | 22.80 | 19608861 | |
211 | Ubiquitination | RLGIAVIHGEAQDAE HHCEEEEECCCCCCH | 22.80 | 19608861 | |
219 | Phosphorylation | GEAQDAESDLVDGRH CCCCCCHHCCCCCCC | 37.66 | 23927012 | |
227 | Phosphorylation | DLVDGRHSPPMVRSV CCCCCCCCCCCHHHH | 29.36 | 29255136 | |
233 | Phosphorylation | HSPPMVRSVAAIHPS CCCCCHHHHEECCCC | 12.51 | 14702039 | |
240 | Phosphorylation | SVAAIHPSLEIPMLI HHEECCCCCCCCEEC | 25.19 | 26074081 | |
251 | Ubiquitination | PMLIPKEKPPITVVG CEECCCCCCCEEEEE | 63.32 | 21890473 | |
251 | Acetylation | PMLIPKEKPPITVVG CEECCCCCCCEEEEE | 63.32 | 19608861 | |
330 | Ubiquitination | TIPHEVQKLQCPKIK CCCHHHHHCCCCCCC | 45.78 | - | |
335 | Ubiquitination | VQKLQCPKIKTVDIS HHHCCCCCCCEEEHH | 65.54 | - | |
338 | Phosphorylation | LQCPKIKTVDISMIL CCCCCCCEEEHHHHH | 27.21 | 20068231 | |
342 | Phosphorylation | KIKTVDISMILSEAI CCCEEEHHHHHHHHH | 8.70 | 20068231 | |
346 | Phosphorylation | VDISMILSEAIRRIH EEHHHHHHHHHHHHH | 17.66 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of KPRB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KPRB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KPRB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
IQGA1_HUMAN | IQGAP1 | physical | 22863883 | |
RU2B_HUMAN | SNRPB2 | physical | 22863883 | |
NS1BP_HUMAN | IVNS1ABP | physical | 28514442 | |
LZTR1_HUMAN | LZTR1 | physical | 28514442 | |
GLT16_HUMAN | GALNT16 | physical | 28514442 | |
PRPS3_HUMAN | PRPS1L1 | physical | 28514442 | |
CCNB1_HUMAN | CCNB1 | physical | 28514442 | |
FNTB_HUMAN | FNTB | physical | 28514442 | |
SNAG_HUMAN | NAPG | physical | 28514442 | |
KAP1_HUMAN | PRKAR1B | physical | 28514442 | |
DOCK7_HUMAN | DOCK7 | physical | 28514442 | |
VTI1B_HUMAN | VTI1B | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-219 AND SER-227, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-251, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-219 AND SER-227, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227, AND MASSSPECTROMETRY. |